{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:27:39Z","timestamp":1770665259011,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.yebeh.2022.108836","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T06:39:13Z","timestamp":1658299153000},"page":"108836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice"],"prefix":"10.1016","volume":"134","author":[{"given":"Pablo","family":"Alonso-Singer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Aguilar-Amat Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Oliva-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreu","family":"Massot-Tarr\u00fas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz G.","family":"Gir\u00e1ldez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"DeToledo-Heras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Aledo-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mart\u00ednez-Cayuelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Tirado-Requero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Vel\u00e1zquez-Fragua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"L\u00f3pez-Sobrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.yebeh.2022.108836_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1528-1157.2001.042suppl.3023.x","article-title":"Epileptic encephalopathy","volume":"42","author":"Dulac","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.eplepsyres.2017.11.015","article-title":"The new definition and classification of seizures and epilepsy","volume":"139","author":"Falco-Walter","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108836_b0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0883073809348355","article-title":"Increased risk of death among children with Lennox-Gastaut syndrome and infantile spasms","volume":"25","author":"Autry","year":"2010","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108836_b0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/epi.12046","article-title":"A population-based study of newly diagnosed epilepsy in infants","volume":"54","author":"Eltze","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.seizure.2018.10.016","article-title":"The pharmacological management of Lennox-Gastaut syndrome and critical literature review","volume":"63","author":"Verrotti","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108836_b0035","doi-asserted-by":"crossref","unstructured":"Khan S, Al Baradie R. Epileptic encephalopathies: an overview. Epilepsy Res Treat 2012;2012: 403592.","DOI":"10.1155\/2012\/403592"},{"key":"10.1016\/j.yebeh.2022.108836_b0040","series-title":"StatPearls [Internet]","article-title":"Lennox Gastaut syndrome","author":"Amrutkar","year":"2020"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108836_b0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10072-017-3188-y","article-title":"Lennox-Gastaut syndrome: a comprehensive review","volume":"39","author":"Asadi-Pooya","year":"2018","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2022.108836_b0050","first-page":"CD003277","article-title":"Treatment of Lennox-Gastaut syndrome","author":"Hancock","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 4","key":"10.1016\/j.yebeh.2022.108836_b0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/epi.12567","article-title":"Lennox-Gastaut syndrome: a consensus approach to differential diagnosis","volume":"55","author":"Bourgeois","year":"2014","journal-title":"Epilepsia"},{"issue":"03","key":"10.1016\/j.yebeh.2022.108836_b0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-0037-1601324","article-title":"Lennox-Gastaut syndrome: A state of the art review","volume":"48","author":"Mastrangelo","year":"2017","journal-title":"Neuropediatrics"},{"issue":"11","key":"10.1016\/j.yebeh.2022.108836_b0065","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/epi.14569","article-title":"Evolution and course of early life developmental encephalopathic epilepsies: Focus on Lennox-Gastaut syndrome","volume":"59","author":"Berg","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0070","doi-asserted-by":"crossref","first-page":"107146","DOI":"10.1016\/j.yebeh.2020.107146","article-title":"Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients","volume":"110","author":"Montouris","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2022.108836_b0075","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.seizure.2013.02.009","article-title":"Long-term outcome after callosotomy or vagus nerve stimulation in consecutive prospective cohorts of children with Lennox-Gastaut or Lennox-like syndrome and non-specific MRI findings","volume":"22","author":"Cukiert","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108836_b0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2019.12.012","article-title":"Open-label, uncontrolled retrospective study of perampanel in adults with Lennox-Gastaut syndrome","volume":"75","author":"Crespel","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108836_b0085","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.seizure.2009.06.005","article-title":"Impact of Lennox-Gastaut syndrome (LGS) on health-related quality of life (HRQL) of patients and caregivers: literature review","volume":"18","author":"Gallop","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108836_b0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1469-8749.2012.04233.x","article-title":"Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution's experience and summary of the literature","volume":"54","author":"Lemmon","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108836_b0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.seizure.2012.09.014","article-title":"Vagus nerve stimulation vs. corpus callosotomy in the treatment of Lennox-Gastaut syndrome: a meta-analysis","volume":"22","author":"Lancman","year":"2013","journal-title":"Seizure"},{"issue":"Suppl 4","key":"10.1016\/j.yebeh.2022.108836_b0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/epi.12742","article-title":"Surgical options for patients with Lennox-Gastaut syndrome","volume":"55","author":"Douglass","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0105","unstructured":"Fycompa (Perampanel): EPAR - Medicine overview. In: European Medicines Agency (EMA); 2012."},{"key":"10.1016\/j.yebeh.2022.108836_b0110","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/epi.12212","article-title":"Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies","volume":"54","author":"Steinhoff","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0115","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108836_b0120","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/epi.14044","article-title":"Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307","volume":"59","author":"Krauss","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0035-1546276","article-title":"Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences","volume":"46","author":"Biro","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2022.108836_b0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eplepsyres.2016.08.001","article-title":"Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study","volume":"126","author":"Villanueva","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108836_b0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yebeh.2016.10.020","article-title":"A two-year retrospective evaluation of perampanel in patients with highly drug-resistant epilepsy and cognitive impairment","volume":"66","author":"Huber","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108836_b0140","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/epi.14522","article-title":"Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study","volume":"59","author":"Villanueva","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0145","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40263-021-00831-y","article-title":"Exploring the evidence for broad-spectrum effectiveness of perampanel: A systematic review of clinical data in generalised seizures","volume":"35","author":"Trinka","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2022.108836_b0150","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00415-021-10751-y","article-title":"PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice","volume":"269","author":"Villanueva","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2022.108836_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2017.05.036","article-title":"Use of perampanel in children and adolescents with Lennox-Gastaut syndrome","volume":"74","author":"Auvin","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108836_b0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11910-019-0933-z","article-title":"Intractable generalized epilepsy: therapeutic approaches","volume":"19","author":"Hwang","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2022.108836_b0165","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2022.108836_b0170","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108836_b0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1528-1157.2000.tb02179.x","article-title":"Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group","volume":"41","author":"Glauser","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0180","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1528-1167.2008.01935.x","article-title":"Clobazam in the treatment of Lennox-Gastaut syndrome","volume":"50","author":"Conry","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108836_b0185","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.0b013e318232de76","article-title":"Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome","volume":"77","author":"Ng","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108836_b0190","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108836_b0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0404.2010.01334.x","article-title":"Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study","volume":"122","author":"Kluger","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2022.108836_b0200","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.eplepsyres.2014.08.019","article-title":"Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan","volume":"108","author":"Ohtsuka","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108836_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2016.01.002","article-title":"Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial","volume":"121","author":"Ohtsuka","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108836_b0210","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2022.108836_b0215","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2022.108836_b0220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pediatrneurol.2003.09.007","article-title":"Levetiracetam in the treatment of Lennox-Gastaut syndrome","volume":"30","author":"de los Reyes","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2022.108836_b0225","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.braindev.2007.09.004","article-title":"Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience","volume":"30","author":"You","year":"2008","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2022.108836_b0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/NRL.0000000000000140","article-title":"Burden of seizure clusters on patients with epilepsy and caregivers: survey of patient, caregiver, and clinician perspectives","volume":"22","author":"Penovich","year":"2017","journal-title":"Neurologist"},{"key":"10.1016\/j.yebeh.2022.108836_b0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1684\/epd.2017.0950","article-title":"Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice","volume":"20","author":"Striano","year":"2018","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2022.108836_b0240","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ane.12572","article-title":"Rufinamide in children and adults in routine clinical practice","volume":"135","author":"Jaraba","year":"2017","journal-title":"Acta Neurol Scand"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022002852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022002852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:47:01Z","timestamp":1761504421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022002852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":48,"alternative-id":["S1525505022002852"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108836","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108836"}}